Conference milestone

Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice

When diabetes tech fails, personalised care fails with it

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.

When the Test Says Normal but the Pain Does Not

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

Cervical Cancer Cannot Be Left Waiting at the Edge of the ADC Era

ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.

ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
